Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative Allogeneic HSCT for CLL
NCT00060424Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Mar 2003
- Primary completion
- Sep 2010
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), prolymphocytic leukemia (PLL), sponsored by Fred Hutchinson Cancer Center. Started Mar 2003; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)prolymphocytic leukemia (PLL)
Beyond the preview
Go deeper on NCT00060424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060424.